Aquestive Therapeutics, Inc. AQST
3.88 USD +0.11 (+2.92%)
At closeNov 3, 2026, 5:28 PM EST
3.78 -0.10 -2.54%
After hours · Nov 3, 5:28 PM ET
3.78 Day range 3.94
2.93 52-week range 6.85
- YTD
- -39.94%
- 1 year
- -40.22%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.83 +179.2% upside
Now 3.88
- Target (low)
- 5.50
- Target (mean)
- 10.83
- Target (high)
- 17.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
- Strong buy4
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.1325 | -0.14 – -0.12 | -0.0917 | -44.5% | 13.11M | -0.7% | 4 |
| Next quarter | -0.1325 | -0.16 – -0.12 | -0.15 | +11.7% | 12.90M | +7.0% | 4 |
| Current year | -0.4225 | -0.50 – -0.33 | -0.062 | -581.5% | 57.50M | +13.7% | 4 |
| Next year | -0.5375 | -0.67 – -0.44 | -0.4225 | -27.2% | 52.97M | -7.9% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 17, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 25, 2024 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 8, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 30, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 30, 2024 | Leerink Partners | Reiterated | Outperform | Outperform |
| Sep 30, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jul 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2024 | Leerink Partners | Initiated | — | Outperform |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 11, 2024 | Piper Sandler | Initiated | — | Overweight |
| Apr 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 28, 2024 | Raymond James | Initiated | — | Outperform |
| Mar 18, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 15, 2024 | JMP Securities | Maintained | Outperform | Outperform |
| Mar 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 7, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Mar 7, 2024 | Lake Street | Maintained | Buy | Buy |
| Nov 8, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 10, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Oct 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 22, 2023 | Wedbush | Reiterated | Outperform | Outperform |